Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.78K Sell
27
-10
-27% -$3.42K ﹤0.01% 381
2026
Q1
$13K Sell
37
-10
-21% -$3.56K ﹤0.01% 368
2025
Q4
$15.4K Hold
47
﹤0.01% 321
2025
Q3
$13.3K Sell
47
-105
-69% -$30.5K ﹤0.01% 352
2025
Q2
$42.4K Buy
+152
New +$43.1K ﹤0.01% 260

Other funds holding AMGN

Alerus Financial's AMGN Position: Q2 2026 in Review

Alerus Financial reduced its Amgen (AMGN) stake by 27% in Q2 2026, selling an estimated $3.42K and leaving 27 shares worth $9.78K. The position accounts for ﹤0.01% of the portfolio, ranked #381.

Alerus Financial first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $42.4K in Q2 2025. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Alerus Financial held 27 shares of Amgen worth $9.78K as of Q2 2026.
  • Alerus Financial sold 10 Amgen shares in Q2 2026, an estimated $3.42K.
  • Amgen made up ﹤0.01% of Alerus Financial's portfolio in Q2 2026, its #381 holding.
  • Alerus Financial first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • Alerus Financial's Amgen position peaked at $42.4K in Q2 2025.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Alerus Financial's 13F filing for Q2 2026, filed 14 Aug 2026.